3B Blackbio Dx Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 176.69 million compared to INR 147.28 million a year ago. Revenue was INR 202.97 million compared to INR 176.09 million a year ago. Net income was INR 87.25 million compared to INR 67.29 million a year ago. Basic earnings per share from continuing operations was INR 9.94 compared to INR 9 a year ago. Diluted earnings per share from continuing operations was INR 9.94 compared to INR 9 a year ago.
For the nine months, sales was INR 511.27 million compared to INR 437.26 million a year ago. Revenue was INR 594.65 million compared to INR 497.98 million a year ago. Net income was INR 238.65 million compared to INR 181.44 million a year ago. Basic earnings per share from continuing operations was INR 27.21 compared to INR 24.21 a year ago. Diluted earnings per share from continuing operations was INR 27.21 compared to INR 24.21 a year ago.